Dynamic Technology Lab Private LTD Chimerix Inc Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.34 - $5.34 $2,692 - $10,728	-2,009 Reduced 14.03%	12,315 $26,000
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $65,603 - $97,403	14,324 New	14,324 $66,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $106,796 - $146,615	-20,420 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $15,919 - $23,450	-2,680 Reduced 11.6%	20,420 $126,000
Q2 2021 Aug 13, 2021	BUY	$7.54 - $9.79 $174,174 - $226,148	23,100 New	23,100 $185,000
Q1 2019 May 13, 2019	SELL	$1.79 - $3.12 $19,170 - $33,415	-10,710 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.24 - $3.9 $23,990 - $41,769	10,710 New	10,710 $28,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.